Cardea Bio Announces $7.8 Million Series A-1 Financing

SAN DIEGO–(BUSINESS WIRE)–Cardea Bio Inc., the world?s leading commercial manufacturer of the first-ever biology-enabled transistor technology made from high-quality graphene-based biosensors, today announced a Series A-1 financing of $7.8 million. The funding will be used to grow the team and initiate new strategic partnerships through the Cardea Innovation Partnership Program, which facilitates co-development and commercialization of novel applications for the advanced biosensor technology.